Clinical Trial Update: A Study to Document Long-Term Safety and Continued Benefit of Irinotecan and Carboplatin or Irinotecan in Subjects With Refractory Solid Tumors (Rollover Study -001, -002) [Phase 1, Phase 2]

View source ↗

Summary

This trial update reports a rollover Phase 1/2 study evaluating long-term safety and continued benefit of irinotecan with or without carboplatin in pediatric pa…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Solid Tumors

Drugs mentioned

• CARBOPLATIN (Carboplatin)
• Irinotecan (Irinotecan)

Snippet

Sponsor: Bristol-Myers Squibb | Conditions: Pediatric Solid Tumors | Phase 1, Phase 2 | Status: COMPLETED